View in EDS

From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.

Saved in:
Bibliographic Details
Title: From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.
Authors: Eltarzy MA; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt., Rabie MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt., Sayed RH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.; Department of Clinical Pharmacy, School of Pharmacy, Newgiza University, Giza, Egypt., Ahmed MAE; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt., Ahmedy OA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.
Source: Drug development research [Drug Dev Res] 2026 Apr; Vol. 87 (2), pp. e70238.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41591821
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Eltarzy+MA%22">Eltarzy MA</searchLink>; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt.<br /><searchLink fieldCode="AU" term="%22Rabie+MA%22">Rabie MA</searchLink>; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.<br /><searchLink fieldCode="AU" term="%22Sayed+RH%22">Sayed RH</searchLink>; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.; Department of Clinical Pharmacy, School of Pharmacy, Newgiza University, Giza, Egypt.<br /><searchLink fieldCode="AU" term="%22Ahmed+MAE%22">Ahmed MAE</searchLink>; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt.<br /><searchLink fieldCode="AU" term="%22Ahmedy+OA%22">Ahmedy OA</searchLink>; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228204468%22">Drug development research</searchLink> [Drug Dev Res] 2026 Apr; Vol. 87 (2), pp. e70238.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8204468 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-2299 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202724391%22">02724391 </searchLink><i>NLM ISO Abbreviation: </i>Drug Dev Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41591821
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ddr.70238
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70238
    Titles:
      – TitleFull: From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Eltarzy MA
      – PersonEntity:
          Name:
            NameFull: Rabie MA
      – PersonEntity:
          Name:
            NameFull: Sayed RH
      – PersonEntity:
          Name:
            NameFull: Ahmed MAE
      – PersonEntity:
          Name:
            NameFull: Ahmedy OA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1098-2299
          Numbering:
            – Type: volume
              Value: 87
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Drug development research
              Type: main
ResultId 1